Support of a bi-faceted role of estrogen receptor β (ERβ) in ERα-positive breast cancer cells

Endocrine-Related Cancer

Volumn 21, Issue 2, 2014, Pages 143-160

  Jonsson, Philip ^a   Katchy, Anne ^a   Williams, Cecilia ^a  

^a University of Houston   (United States)

Author keywords

Breast cancer; Estrogen receptor ; Estrogen receptor ; Gene expression; SERM

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; GENE CONTROL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MCF 7 CELL LINE; SIGNAL TRANSDUCTION; TRANSIENT EXPRESSION;

BREAST CANCER; ESTROGEN RECEPTOR Α; ESTROGEN RECEPTOR Β; GENE EXPRESSION; SERM;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; POLY(ADP-RIBOSE) POLYMERASES; TRANSCRIPTION, GENETIC; WOUND HEALING;

EID: 84899785858     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-13-0444     Document Type: Article

References (102)

1. Alonso-Magdalena P, Brossner C, Reiner A, Cheng G, Sugiyama N, Warner M & Gustafsson JA 2009 A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia. PNAS 106 2859-2863. (doi:10.1073/pnas.0812666106)
2. Alvarez-Baron CP, Jonsson P, Thomas C, Dryer SE & Williams C 2011 The two-pore domain potassium channel KCNK5: induction by estrogen receptor a and role in proliferation of breast cancer cells. Molecular Endocrinology 25 1326-1336. (doi:10.1210/me.2011-0045)
3. Bierie B & Moses HL 2009 Gain or loss of TGFb signaling in mammary carcinoma cells can promote metastasis. Cell Cycle 8 3319-3327. (doi:10.4161/cc.8.20.9727)
4. Braun L, Mietzsch F, Seibold P, Schneeweiss A, Schirmacher P, Chang-Claude J, Peter Sinn H & Aulmann S 2013 Intrinsic breast cancer subtypes defined by estrogen receptor signalling-prognostic relevance of progesterone receptor loss. Modern Pathology 26 1161-1171. (doi:10.1038/ modpathol.2013.60)
5. Buck MB & Knabbe C 2006 TGF-b signaling in breast cancer. Annals of the New York Academy of Sciences 1089 119-126. (doi:10.1196/annals. 1386.024)
6. Castles CG, Oesterreich S, Hansen R & Fuqua SA 1997 Auto-regulation of the estrogen receptor promoter. Journal of Steroid Biochemistry and Molecular Biology 62 155-163. (doi:10.1016/S0960-0760(97)00023-X)
7. Cavailles V, Augereau P & Rochefort H 1993 Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cells. PNAS 90 203-207. (doi:10.1073/pnas.90.1. 203)
8. Chang EC, Frasor J, Komm B & Katzenellenbogen BS 2006 Impact of estrogen receptor b on gene networks regulated by estrogen receptor a in breast cancer cells. Endocrinology 147 4831-4842. (doi:10.1210/en.2006-0563)
9. Charn TH, Liu ET, Chang EC, Lee YK, Katzenellenbogen JA & Katzenellenbogen BS 2010 Genome-wide dynamics of chromatin binding of estrogen receptors a and b: mutual restriction and competitive site selection. Molecular Endocrinology 24 47-59. (doi:10.1210/me.2009-0252)
10. Cheung E, Acevedo ML, Cole PA & Kraus WL 2005 Altered pharmacology and distinct coactivator usage for estrogen receptor-dependent transcription through activating protein-1. PNAS 102 559-564. (doi:10.1073/pnas.0407113102)
11. Cotrim CZ, Fabris V, Doria ML, Lindberg K, Gustafsson JA, Amado F, Lanari C & Helguero LA 2013 Estrogen receptor b growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells. Oncogene 32 2390-2402.
12. Dahlman-Wright K, Qiao Y, Jonsson P, Gustafsson JA, Williams C & Zhao C 2012 Interplay between AP-1 and estrogen receptor a in regulating gene expression and proliferation networks in breast cancer cells. Carcinogenesis 33 1684-1691. (doi:10.1093/carcin/bgs223)
13. Dey P, Jonsson P, Hartman J, Williams C, Strom A & Gustafsson JA 2012 Estrogen receptors b1 and b2 have opposing roles in regulating proliferation and bone metastasis genes in the prostate cancer cell line PC3. Molecular Endocrinology 26 1991-2003. (doi:10.1210/me.2012.1227)
14. Donaghue C, Westley BR & May FE 1999 Selective promoter usage of the human estrogen receptor-A gene and its regulation by estrogen. Molecular Endocrinology 13 1934-1950. (doi:10.1210/me.13.11.1934)
15. Dubik D & Shiu RP 1992 Mechanism of estrogen activation of c-myc oncogene expression. Oncogene 7 1587-1594.
16. Edvardsson K, Strom A, Jonsson P, Gustafsson JA & Williams C 2011 Estrogen receptor b induces antiinflammatory and antitumorigenic networks in colon cancer cells. Molecular Endocrinology 25 969-979. (doi:10.1210/me.2010- 0452)
17. Edvardsson K, Nguyen-Vu T, Kalasekar SM, Ponten F, Gustafsson JA & Williams C 2013 Estrogen receptor b expression induces changes in the microRNA pool in human colon cancer cells. Carcinogenesis 34 1431-1441. (doi:10.1093/carcin/bgt067)
18. Foekens JA, Look MP, Bolt-de Vries J, Meijer-van Gelder ME, van Putten WL & Klijn JG 1999 Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients. British Journal of Cancer 79 300-307. (doi:10.1038/sj.bjc.6690048)
19. Frasor J, Danes JM, Komm B, Chang KC, Lyttle CR & Katzenellenbogen BS 2003 Profiling of estrogen up-and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144 4562-4574. (doi:10.1210/en.2003-0567)
20. Frasor J, Stossi F, Danes JM, Komm B, Lyttle CR & Katzenellenbogen BS 2004 Selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells. Cancer Research 64 1522-1533. (doi:10.1158/0008-5472.CAN-03-3326)
21. Fuqua SA, Schiff R, Parra I, Moore JT, Mohsin SK, Osborne CK, Clark GM & Allred DC 2003 Estrogen receptor b protein in human breast cancer: correlation with clinical tumor parameters. Cancer Research 63 2434-2439.
22. Goto N, Hiyoshi H, Ito I, Tsuchiya M, Nakajima Y & Yanagisawa J 2011 Estrogen and antiestrogens alter breast cancer invasiveness by modulating the transforming growth factor-b signaling pathway. Cancer Science 102 1501-1508. (doi:10.1111/j.1349-7006.2011. 01977.x)
23. Grober OM, Mutarelli M, Giurato G, Ravo M, Cicatiello L, De Filippo MR, Ferraro L, Nassa G, Papa MF, Paris O et al. 2011 Global analysis of estrogen receptor b binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor a for target gene regulation. BMC Genomics 12 36. (doi:10.1186/1471-2164-12-36)
24. Hah N, Danko CG, Core L, Waterfall JJ, Siepel A, Lis JT & Kraus WL 2011 A rapid, extensive, and transient transcriptional response to estrogen signaling in breast cancer cells. Cell 145 622-634. (doi:10.1016/j.cell.2011.03. 042)
25. Hall JM & McDonnell DP 1999 The estrogen receptor b-isoform (ERb) of the human estrogen receptor modulates ERa transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 140 5566-5578. (doi:10.1210/en.140.12.5566)
26. Hartman J, Edvardsson K, Lindberg K, Zhao C, Williams C, Strom A & Gustafsson JA 2009 Tumor repressive functions of estrogen receptor b in SW480 colon cancer cells. Cancer Research 69 6100-6106. (doi:10.1158/0008-5472.CAN-09- 0506)
27. Hawse JR, Subramaniam M, Monroe DG, Hemmingsen AH, Ingle JN, Khosla S, Oursler MJ & Spelsberg TC 2008 Estrogen receptor b isoform-specific induction of transforming growth factor b-inducible early gene-1 in human osteoblast cells: an essential role for the activation function 1 domain. Molecular Endocrinology 22 1579-1595. (doi:10.1210/me.2007-0253)
28. Helguero LA, Faulds MH, Gustafsson JA & Haldosen LA 2005 Estrogen receptors a (ERa) and b (ERb) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11. Oncogene 24 6605-6616. (doi:10.1038/sj.onc.1208807)
29. Hodges-Gallagher L, Valentine CD, El Bader S & Kushner PJ 2008 Estrogen receptor b increases the efficacy of antiestrogens by effects on apoptosis and cell cycling in breast cancer cells. Breast Cancer Research and Treatment 109 241-250. (doi:10.1007/s10549-007-9640-6)
30. Holbeck S, Chang J, Best AM, Bookout AL, Mangelsdorf DJ & Martinez ED 2010 Expression profiling of nuclear receptors in the NCI60 cancer cell panel reveals receptor-drug and receptor-gene interactions. Molecular Endocrinology 24 1287-1296. (doi:10.1210/me.2010-0040)
31. Honma N, Horii R, Iwase T, Saji S, Younes M, Takubo K, Matsuura M, Ito Y, Akiyama F & Sakamoto G 2008 Clinical importance of estrogen receptor-b evaluation in breast cancer patients treated with adjuvant tamoxifen therapy. Journal of Clinical Oncology 26 3727-3734. (doi:10.1200/JCO.2007.14.2968)
32. Honma N, Horii R, Iwase T, Saji S, Younes M, Ito Y & Akiyama F 2013 Ki-67 evaluation at the hottest spot predicts clinical outcome of patients with hormone receptor-positive/HER2-negative breast cancer treated with adjuvant tamoxifen monotherapy. Breast Cancer [in press]. (doi:10.1007/s12282-013-0455-5)
33. Hopp TA, Weiss HL, Parra IS, Cui Y, Osborne CK & Fuqua SA 2004 Low levels of estrogen receptor b protein predict resistance to tamoxifen therapy in breast cancer. Clinical Cancer Research 10 7490-7499. (doi:10.1158/1078-0432. CCR-04-1114)
34. Horimoto Y, Hartman J, Millour J, Pollock S, Olmos Y, Ho KK, Coombes RC, Poutanen M, Makela SI, El-Bahrawy M et al. 2011 ERb1 represses FOXM1 expression through targeting ERa to control cell proliferation in breast cancer. American Journal of Pathology 179 1148-1156. (doi:10.1016/j.ajpath.2011.05.052)
35. Hou YF, Yuan ST, Li HC, Wu J, Lu JS, Liu G, Lu LJ, Shen ZZ, Ding J & Shao ZM 2004 ERb exerts multiple stimulative effects on human breast carcinoma cells. Oncogene 23 5799-5806. (doi:10.1038/sj.onc.1207765)
36. Hussain S, Lawrence MG, Taylor RA, Lo CY, Frydenberg M, Ellem SJ, Furic L & Risbridger GP 2012 Estrogen receptor b activation impairs prostatic regeneration by inducing apoptosis in murine and human stem/progenitor enriched cell populations. PLoS ONE 7 e40732. (doi:10.1371/journal.pone.0040732)
37. Jensen EV, Cheng G, Palmieri C, Saji S, Makela S, Van Noorden S, Wahlstrom T, Warner M, Coombes RC & Gustafsson JA 2001 Estrogen receptors and proliferation markers in primary and recurrent breast cancer. PNAS 98 15197-15202. (doi:10.1073/pnas.211556298)
38. Kao J, Salari K, Bocanegra M, Choi YL, Girard L, Gandhi J, Kwei KA, Hernandez-Boussard T, Wang P, Gazdar AF et al. 2009 Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS ONE 4 e6146. (doi:10.1371/journal.pone.0006146)
39. Katchy A, Edvardsson K, Aydogdu E & Williams C 2012 Estradiol-activated estrogen receptor a does not regulate mature microRNAs in T47D breast cancer cells. Journal of Steroid Biochemistry and Molecular Biology 128 145-153. (doi:10.1016/j.jsbmb.2011.10.008)
40. Koehler KF, Helguero LA, Haldosen LA, Warner M & Gustafsson JA 2005 Reflections on the discovery and significance of estrogen receptor b. Endocrine Reviews 26 465-478. (doi:10.1210/er.2004-0027)
41. Krishnan V, Wang X & Safe S 1994 Estrogen receptor-Sp1 complexes mediate estrogen-induced Cathepsin D gene expression in MCF-7 human breast cancer cells. Journal of Biological Chemistry 269 15912-15917.
42. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S & Gustafsson JA 1996 Cloning of a novel receptor expressed in rat prostate and ovary. PNAS 93 5925-5930. (doi:10.1073/pnas.93.12.5925)
43. Lacroix M & Leclercq G 2004 Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Research and Treatment 83 249-289. (doi:10.1023/B:BREA.0000014042.54925.cc)
44. Lam HM, Suresh Babu CV, Wang J, Yuan Y, Lam YW, Ho SM & Leung YK 2012 Phosphorylation of human estrogen receptor-b at serine 105 inhibits breast cancer cell migration and invasion. Molecular and Cellular Endocrinology 358 27-35. (doi:10.1016/j.mce.2012.02.012)
45. Lazennec G, Bresson D, Lucas A, Chauveau C & Vignon F 2001 ERb inhibits proliferation and invasion of breast cancer cells. Endocrinology 142 4120-4130. (doi:10.1210/en.142.9.4120)
46. Lewis JS, Meeke K, Osipo C, Ross EA, Kidawi N, Li T, Bell E, Chandel NS & Jordan VC 2005 Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation. Journal of the National Cancer Institute 97 1746-1759. (doi:10.1093/jnci/dji400)
47. Leygue E & Murphy LC 2013 A bi-faceted role of estrogen receptor b in breast cancer. Endocrine-Related Cancer 20 R127-R139. (doi:10.1530/ERC-12-0389)
48. Li X, Huang J, Yi P, Bambara RA, Hilf R & Muyan M 2004 Single-chain estrogen receptors (ERs) reveal that the ERa/b heterodimer emulates functions of the ERa dimer in genomic estrogen signaling pathways. Molecular and Cellular Biology 24 7681-7694. (doi:10.1128/MCB.24.17. 7681-7694.2004)
49. Li S, Han B, Liu G, Ouellet J, Labrie F & Pelletier G 2010a Immunocyto-chemical localization of sex steroid hormone receptors in normal human mammary gland. Journal of Histochemistry and Cytochemistry 58 509-515. (doi:10.1369/jhc.2009.954644)
50. Li Y, Wang JP, Santen RJ, Kim TH, Park H, Fan P & Yue W 2010b Estrogen stimulation of cell migration involves multiple signaling pathway interactions. Endocrinology151 5146-5156. (doi:10.1210/en.2009-1506)
51. Lindberg K, Strom A, Lock JG, Gustafsson JA, Haldosen LA & Helguero LA 2010 Expression of estrogen receptor b increases integrin a1 and integrin b1 levels and enhances adhesion of breast cancer cells. Journal of Cellular Physiology 222 156-167. (doi:10.1002/jcp.21932)
52. Marotti JD, Collins LC, Hu R & Tamimi RM 2010 Estrogen receptor-b expression in invasive breast cancer in relation to molecular pheno-type: results from the Nurses' Health Study. Modern Pathology 23 197-204. (doi:10.1038/modpathol.2009.158)
53. Matthews J & Gustafsson JA 2003 Estrogen signaling: a subtle balance between ERa and ERb. Molecular interventions 3 281-292. (doi:10.1124/mi.3.5.281)
54. Matthews J, Wihlen B, Tujague M, Wan J, Strom A & Gustafsson JA 2006 Estrogen receptor (ER) b modulates ERa-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters. Molecular Endocrinology 20 534-543. (doi:10.1210/me.2005-0140)
55. Mendez P, Azcoitia I & Garcia-Segura LM 2003 Estrogen receptor a forms estrogen-dependent multimolecular complexes with insulin-like growth factor receptor and phosphatidylinositol 3-kinase in the adult rat brain. Brain Research. Molecular Brain Research 112 170-176. (doi:10.1016/S0169-328X(03) 00088-3)
56. Meyer ME, Gronemeyer H, Turcotte B, Bocquel MT, Tasset D & Chambon P 1989 Steroid hormone receptors compete for factors that mediate their enhancer function. Cell 57 433-442. (doi:10.1016/0092-8674(89)90918-5)
57. Moghadam SJ, Hanks AM & Keyomarsi K 2011 Breaking the cycle: an insight into the role of ERa in eukaryotic cell cycles. Journal of Carcinogenesis 10 25. (doi:10.4103/1477-3163.90440)
58. Mosselman S, Polman J & Dijkema R 1996 ERb: identification and characterization of a novel human estrogen receptor. FEBS Letters 392 49-53. (doi:10.1016/0014-5793(96)00782-X)
59. Murphy LC & Leygue E 2012 The role of estrogen receptor-b in breast cancer. Seminars in Reproductive Medicine 30 5-13. (doi:10.1055/s-0031-1299592)
60. Nakopoulou L, Lazaris AC, Panayotopoulou EG, Giannopoulou I, Givalos N, Markaki S & Keramopoulos A 2004 The favourable prognostic value of oestrogen receptor b immunohistochemical expression in breast cancer. Journal of Clinical Pathology 57 523-528. (doi:10.1136/jcp.2003. 008599)
61. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F et al. 2006 A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10 515-527. (doi:10.1016/j.ccr.2006.10.008)
62. Novelli F, Milella M, Melucci E, Di Benedetto A, Sperduti I, Perrone-Donnorso R, Perracchio L, Venturo I, Nistico C, Fabi A et al. 2008 A divergent role for estrogen receptor-b in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study. Breast Cancer 10 R74. (doi:10.1186/bcr2139)
63. Ohshiro K, Schwartz AM, Levine PH & Kumar R 2012 Alternate estrogen receptors promote invasion of inflammatory breast cancer cells via non-genomic signaling. PLoS ONE 7 e30725. (doi:10.1371/journal. pone.0030725)
64. Omoto Y, Inoue S, Ogawa S, Toyama T, Yamashita H, Muramatsu M, Kobayashi S & Iwase H 2001 Clinical value of the wild-type estrogen receptor b expression in breast cancer. Cancer Letters 163 207-212. (doi:10.1016/S0304- 3835(00)00680-7)
65. O'Neill PA, Davies MP, Shaaban AM, Innes H, Torevell A, Sibson DR & Foster CS 2004 Wild-type oestrogen receptor b (ERb1) mRNA and protein expression in tamoxifen-treated post-menopausal breast cancers. British Journal of Cancer 91 1694-1702. (doi:10.1038/sj.bjc. 6602183)
66. Pace P, Taylor J, Suntharalingam S, Coombes RC & Ali S 1997 Human estrogen receptor b binds DNA in a manner similar to and dimerizes with estrogen receptor a. Journal of Biological Chemistry 272 25832-25838. (doi:10.1074/jbc.272.41.25832)
67. Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ & Scanlan TS 1997 Differential ligand activation of estrogen receptors ERa and ERb at AP1 sites. Science 277 1508-1510. (doi:10.1126/science.277.5331.1508)
68. Palmieri C, Cheng GJ, Saji S, Zelada-Hedman M, Warri A, Weihua Z, Van Noorden S, Wahlstrom T, Coombes RC, Warner M et al. 2002 Estrogen receptor b in breast cancer. Endocrine-Related Cancer 9 1-13. (doi:10.1677/erc.0.0090001)
69. Papoutsi Z, Zhao C, Putnik M, Gustafsson JA & Dahlman-Wright K 2009 Binding of estrogen receptor a/b heterodimers to chromatin in MCF-7 cells. Journal of Molecular Endocrinology 43 65-72. (doi:10.1677/JME-08-0177)
70. Paruthiyil S, Parmar H, Kerekatte V, Cunha GR, Firestone GL & Leitman DC 2004 Estrogen receptor b inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Research 64 423-428. (doi:10.1158/0008-5472.CAN-03-2446)
71. Pawlak KJ & Wiebe JP 2007 Regulation of estrogen receptor (ER) levels in MCF-7 cells by progesterone metabolites. Journal of Steroid Biochemistry and Molecular Biology 107 172-179. (doi:10.1016/j.jsbmb.2007.05.030)
72. Pettersson K, Delaunay F & Gustafsson JA 2000 Estrogen receptor b acts as a dominant regulator of estrogen signaling. Oncogene 19 4970-4978. (doi:10.1038/sj.onc.1203828)
73. Powell E, Shanle E, Brinkman A, Li J, Keles S, Wisinski KB, Huang W & Xu W 2012 Identification of estrogen receptor dimer selective ligands reveals growth-inhibitory effects on cells that co-express ERa and ERb. PLoS ONE 7 e30993. (doi:10.1371/journal.pone.0030993)
74. Rasband WS 1997 ImageJ. Bethesda, Maryland, USA: U.S. National Institutes of Health. (available at: http://imagej.nih.gov/ij/)
75. Roger P, Sahla ME, Makela S, Gustafsson JA, Baldet P & Rochefort H 2001 Decreased expression of estrogen receptor b protein in proliferative preinvasive mammary tumors. Cancer Research 61 2537-2541.
76. Ross DT & Perou CM 2001 A comparison of gene expression signatures from breast tumors and breast tissue derived cell lines. Disease Markers 17 99-109. (doi:10.1155/2001/850531)
77. Rousseau C, Nichol JN, Pettersson F, Couture MC & Miller WH Jr 2004 ERb sensitizes breast cancer cells to retinoic acid: evidence of transcriptional crosstalk. Molecular Cancer Research 2 523-531.
78. Saunders PT 2006 Estrogen receptor b: the 'new' estrogen receptor implicated in breast cancer. Dako Scientific Magazine Connection 9 12-14.
79. Sayers EW, Barrett T, Benson DA, Bolton E, Bryant SH, Canese K, Chetvernin V, Church DM, Dicuccio M, Federhen S et al. 2012 Database resources of the National Center for Biotechnology Information. Nucleic Acids Research 40 D13-D25. (doi:10.1093/nar/gkr1184)
80. Shaaban AM, O'Neill PA, Davies MP, Sibson R, West CR, Smith PH & Foster CS 2003 Declining estrogen receptor-b expression defines malignant progression of human breast neoplasia. American Journal of Surgical Pathology 27 1502-1512. (doi:10.1097/00000478-200312000-00002)
81. Shaaban AM, Green AR, Karthik S, Alizadeh Y, Hughes TA, Harkins L, Ellis IO, Robertson JF, Paish EC, Saunders PT et al. 2008 Nuclear and cytoplasmic expression of ERb1, ERb2, and ERb5 identifies distinct prognostic outcome for breast cancer patients. Clinical Cancer Research 14 5228-5235. (doi:10.1158/1078-0432.CCR-07-4528)
82. Song RX, Mor G, Naftolin F, McPherson RA, Song J, Zhang Z, Yue W, Wang J & Santen RJ 2001 Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17b-estradiol. Journal of the National Cancer Institute 93 1714-1723. (doi:10.1093/jnci/93.22.1714)
83. Speirs V, Skliris GP, Burdall SE & Carder PJ 2002 Distinct expression patterns of ERa and ERb in normal human mammary gland. Journal of Clinical Pathology 55 371-374. (doi:10.1136/jcp.55.5.371)
84. Speirs V, Carder PJ, Lane S, Dodwell D, Lansdown MR & Hanby AM 2004 Oestrogen receptor b: what it means for patients with breast cancer. Lancet Oncology 5 174-181. (doi:10.1016/S1470-2045(04)01413-5)
85. Stender JD, Frasor J, Komm B, Chang KC, Kraus WL & Katzenellenbogen BS 2007 Estrogen-regulated gene networks in human breast cancer cells: involvement of E2F1 in the regulation of cell proliferation. Molecular Endocrinology 21 2112-2123. (doi:10.1210/me.2006-0474)
86. Strom A, Hartman J, Foster JS, Kietz S, Wimalasena J & Gustafsson JA 2004 Estrogen receptor b inhibits 17b-estradiol-stimulated proliferation of the breast cancer cell line T47D. PNAS 101 1566-1571. (doi:10.1073/pnas.0308319100)
87. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES et al. 2005 Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. PNAS 102 15545-15550. (doi:10.1073/pnas.0506580102)
88. Sugiura H, Toyama T, Hara Y, Zhang Z, Kobayashi S, Fujii Y, Iwase H & Yamashita H 2007 Expression of estrogen receptor b wild-type and its variant ERbcx/b2 is correlated with better prognosis in breast cancer. Japanese Journal of Clinical Oncology 37 820-828. (doi:10.1093/jjco/hym114)
89. Thomas C, Rajapaksa G, Nikolos F, Hao R, Katchy A, McCollum CW, Bondesson M, Quinlan P, Thompson A, Krishnamurthy S et al. 2012 ERb1 represses basal-like breast cancer epithelial to mesenchymal transition by destabilizing EGFR. Breast Cancer Research 14 R148. (doi:10.1186/bcr3358)
90. Tolhurst RS, Thomas RS, Kyle FJ, Patel H, Periyasamy M, Photiou A, Thiruchelvam PT, Lai CF, Al-Sabbagh M, Fisher RA et al. 2011 Transient over-expression of estrogen receptor-A in breast cancer cells promotes cell survival and estrogen-independent growth. Breast Cancer Research and Treatment 128 357-368. (doi:10.1007/s10549-010-1122-6)
91. Tonetti DA, Rubenstein R, DeLeon M, Zhao H, Pappas SG, Bentrem DJ, Chen B, Constantinou A & Craig Jordan V 2003 Stable transfection of an estrogen receptor b cDNA isoform into MDA-MB-231 breast cancer cells. Journal of Steroid Biochemistry and Molecular Biology 87 47-55. (doi:10.1016/j.jsbmb.2003.07.003)
92. Tong GM, Rajah TT, Zang XP & Pento JT 2002 The effect of antiestrogens on TGF-b-mediated chemotaxis of human breast cancer cells. Anticancer Research 22 103-106.
93. Vivar OI, Zhao X, Saunier EF, Griffin C, Mayba OS, Tagliaferri M, Cohen I, Speed TP & Leitman DC 2010 Estrogen receptor b binds to and regulates three distinct classes of target genes. Journal of Biological Chemistry 285 22059-22066. (doi:10.1074/jbc.M110.114116)
94. Wang W, Dong L, Saville B & Safe S 1999 Transcriptional activation of E2F1 gene expression by 17b-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions. Molecular Endocrinology 13 1373-1387. (doi:10.1210/me.13.8.1373)
95. Warnmark A, Wikstrom A, Wright AP, Gustafsson JA & Hard T 2001 The N-terminal regions of estrogen receptor a and b are unstructured in vitro and show different TBP binding properties. Journal of Biological Chemistry 276 45939-45944. (doi:10.1074/jbc.M107875200)
96. Williams C, Edvardsson K, Lewandowski SA, Strom A & Gustafsson JA 2008 A genome-wide study of the repressive effects of estrogen receptor b on estrogen receptor a signaling in breast cancer cells. Oncogene 27 1019-1032. (doi:10.1038/sj.onc.1210712)
97. Wu X, Subramaniam M, Grygo SB, Sun Z, Negron V, Lingle WL, Goetz MP, Ingle JN, Spelsberg TC & Hawse JR 2011 Estrogen receptor-b sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen. Breast Cancer Research 13 R27. (doi:10.1186/bcr2844)
98. Yam CH, Fung TK & Poon RY 2002 Cyclin A in cell cycle control and cancer. Cellular and Molecular Life Sciences 59 1317-1326. (doi:10.1007/s00018- 002-8510-y)
99. Zajchowski DA, Sager R & Webster L 1993 Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor. Cancer Research 53 5004-5011.
100. Zhao C, Dahlman-Wright K & Gustafsson JA 2008 Estrogen receptor b: an overview and update. Nuclear Receptor Signaling 6 e003. (doi:10.1621/nrs.06003)
101. Zhao C, Gao H, Liu Y, Papoutsi Z, Jaffrey S, Gustafsson JA & Dahlman-Wright K 2010 Genome-wide mapping of estrogen receptor-b-binding regions reveals extensive cross-talk with transcription factor activator protein-1. Cancer Research 70 5174-5183. (doi:10.1158/0008-5472. CAN-09-4407)
102. Zhou XL, Qin XR, Zhang XD & Ye LH 2010 Downregulation of Dickkopf-1 is responsible for high proliferation of breast cancer cells via losing control of Wnt/b-catenin signaling. Acta Pharmacologica Sinica 31 202-210. (doi:10.1038/aps.2009.200)